Search
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Hovione and Zerion Pharma announce a strategic partnership to market the Dispersome® technology platform
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.
Hovione announces New Pharma Campus expansion in New Jersey
This expansion in New Jersey will create up to 100 jobs over the next few years is part of a global expansion strategy
Contract Pharma visited an expanding New Jersey facility, and launched a new audience service
Contract Pharma, The Friday Brief, 1 May 2026
The good times keep rolling in pharmaceutical chemicals
C&EN, May 21, 2018
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.
Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents